Gapping down in pre-market trading. I seriously doubt a close above $14 today. While the drug approval was great news for the scientists in the lab, it just isn't going to generate any revenue for this company.
Sentiment: Strong Sell
Looks like you called it right Intelect. Short at will here folks, won't be in the 14's much longer.
O Goodness! Looks like it is really tanking. Sell the news - here it comes - TIMBER. There is no value in this drug... etc.
Looks like a lot of people do not know how to evaluate this company.